1.
Surawicz B: Relationship between electrocardiogram and electrolytes. Am Heart J 1967;73:814–834.
2.
Bashour T, Hsu I, Gorfinkel HJ, Wickramesekaran R, Rios JC: Atrioventricular and intraventricular conduction in hyperkalemia. Am J Cardiol 1975;35:199–203.
3.
Hashimoto K, Suzuki Y, Chiba S: Effect of potassium excess on pacemaker activity of canine sinoatrial node in vivo. Am J Physiol 1970;218:83–87.
4.
Cohen HC, Rosen KM, Pick A: Disorders of impulse conduction and impulse formation caused by hyperkalemia in man Am Heart J 1975;89:501–509.
5.
Podlaha R, Falk A: The prevalence of diabetes mellitus and other risk factors of atherosclerosis in bradycardia requiring pacemaker treatment. Horm Metab Res Suppl 1992;26:84–87.
6.
Hossack KF: Conduction abnormalities due to diltiazem. N Engl J Med 1982;307:953–954.
7.
Jakubowski AT, Mizgala HF: Effect of diltiazem overdose. Am J Cardiol 1987;60:932–933.
8.
Connolly DL, Nettleton MA, Bastow MD: Massive diltiazem overdose. Am J Cardiol 1993;72:742–743.
9.
Jolly SR, Keaton N, Movahed A, Rose GC, Reeves WC: Effect of hyperkalemia on experimental myocardial depression by verapamil. Am Heart J 1991;121:517–523.
10.
Pritza R, Bierman MH, Hammeke MD: Acute toxic effects of sustained-release verapamil in chronic renal failure. Arch Intern Med 1991;151:2081–2084.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.